References
- Davis LE, Hudson D, Benson BE, Jones Easom LA, Coleman JK. Methanol poisoning exposures in the United States: 1993–1998. J Toxicol Clin Toxicol 2002;40:499–505.
- Pakravan M, Esfandiari H, Sanjari N, Ghahari E. Erythropoietin as an adjunctive treatment for the treatment of methanol-induced toxic optic neuropathy. Am J Drug Alcohol Abuse in press.
- Gulmen MK, Meral D, Hilal A, Akcan R, Cekin N. Methanol intoxications in Adana, Turkey. Toxicol Mech Methods 2006;16:353–357.
- Zhang G, Crews K, Wiseman H, Bates N, Hovda KE, Archer JRH, Dargan PI. Application to include fomepizole on the WHO model list of essential medicines. 2012.
- Hall W. What are the policy lessons of national alcohol prohibition in the United States, 1920–1933? Addiction 2010;105:1164–1173.
- Blocker JS, Jr. Did prohibition really work? Alcohol prohibition as a public health innovation. Am J Public Health 2006;96:233–243.
- Lerner MA. Dry Manhattan: prohibition in New York City. Cambridge, MA: Harvard University Press, 2008.
- Baum D. Smoke and mirrors: the war and drugs and the politics of failure. Waltham, MA: Little, Brown and Co; 1996.
- Mitchell O, Caudy MS. Examing racial disparaties in drug arrests. Justice Q 2015;32:288–313.
- Robinson M, Scherlen RG. Lies, damned lies, and drug war statistics, second edition: a critical analysis of claims made by the office of national drug control policy. Albany, NY: State University of New York Press, 2014.
- Kanouse AB, Compton P. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response. J Pain Palliative Care Pharmacother 2015;29:102–114.
- Trends in Current Cigarette Smoking Among High School Students and Adults, United States, 1965–2014. 2016. http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/(accessed July 18 2016).
- Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey on Drug Use and Health: Underage drinking declined between 2002–2013. In The CBHSQ Report, 2015.
- Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, Cepeda J, Comfort M, Goosby E, Goulao J, Hart C, Kerr T, Lajous AM, Lewis S, Martin N, Mejia D, Camacho A, Mathieson D, Obot I, Ogunrombi A, Sherman S, Stone J, Vallath N, Vickerman P, Zabransky T, Beyrer C. Public health and international drug policy. Lancet 2016;387:1427–1480.
- Law Enforcement Against Prohibition (LEAP). http://www.leap.cc/(accessed July 19 2016).
- Global Commission on Drug Policy. Taking Control: Pathways to Drug Policies that Work. 2014.
- Laqueur H. Uses and abuses of drug decriminalization in Portugal. Law Social Inq 2015;40:746–781.
- Hughes CE, Stevens A. What can we learn from the Portuguese decriminalization of illicit drugs? Br J Criminol 2010;50:999–1022.
- Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Internal Med 2014;174:1668–1673.
- Lynne-Landsman SD, Livingston MD, Wagenaar AC. Effects of state medical marijuana laws on adolescent marijuana use. Am J Public Health 2013;103:1500–1506.
- Hasin DS, Wall M, Keyes KM, Cerda M, Schulenberg J, O’Malley PM, Galea S, Pacula R, Feng T. Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys. Lancet Psychiatry 2015;2:601–608.
- Keyes KM, Wall M, Cerda M, Schulenberg J, O’Malley PM, Galea S, Feng T, Hasin DS. How does state marijuana policy affect U.S. youth? Medical marijuana laws, marijuana use and perceived harmfulness: 1991–2014. Addiction 2016.
- Brodrick JE, Brodrick CK, Adinoff B. Legal regimes surrounding naloxone access: considerations for prescribers. Am J Drug Alcohol Abuse 2016;42:117–128.
- Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry 2007;191:55–62.
- DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, Montaner J, Wood E. Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug Alcohol Depend 2011;113:172–176.
- European Monitoring Centre for Drugs and Drug Addiction. Perspectives On Drugs: Drug consumption rooms: an overview of provision and evidence. April 2015, 2.
- Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, Kohler WK, Passie T, Soyka M, Tanger S, Vogel M, Haasen C. Long-term effects of heroin-assisted treatment in Germany. Addiction 2008;103: 960–966; discussion 967–968.
- Dargmar H. European Report on Drug Consumption Rooms. Lisbon, Portugal: European Monitoring Centre on Drugs and Drug Addiction, 2004, 81.
- Wright NM, Tompkins CN. Supervised injecting centres. BMJ 2004;328:100–102.